NCT05076357

Brief Summary

This study is an 8 week weight loss intervention with 3 randomly assigned groups: DIET, cold exposure (CE), and DIET+CE. The study will be a total of 13 weeks. All participants will undergo a screening session, two experimental sessions at baseline and two experimental sessions after the intervention. There will be a control (ambient) experimental session and a cold exposure experimental session These will be done in a randomized order both before and after the intervention. Therefore, a total of 5 lab visits will be required for all participants regardless of group outside of their assigned group intervention. Participants in the CE and DIET+CE groups will report to the laboratory every 2nd day for the 8 week intervention to undergo cold exposure as outlined below. The DIET and DIET+CE groups will have a weekly nutritional consultation at the lab as well as a weekly check-in with the nutritionist via text, phone, or email. Participants will be randomly assigned a group after completing the screening session and prior to the experimental session.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 26, 2021

Completed
6 months until next milestone

First Posted

Study publicly available on registry

October 13, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

February 1, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2022

Completed
2.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2024

Completed
Last Updated

April 27, 2022

Status Verified

April 1, 2022

Enrollment Period

7 months

First QC Date

April 26, 2021

Last Update Submit

April 19, 2022

Conditions

Keywords

weight lossappetitecold exposureobesitynutritional intervention

Outcome Measures

Primary Outcomes (9)

  • Change from baseline energy intake at 8 weeks

    Energy intake will be measured both in the laboratory and in the free-living state for 3 days with a validated food menu (McNeil, 2012) and the Food Processor SQL from ESHA Research, Inc. Measures will be taken at baseline and after intervention.

    8 weeks

  • Change from baseline in fasting hunger using Visual Analogue scales at 8 weeks

    Measures of fasting hunger using Visual Analogue scales will be performed in fasting state (12h) at baseline and in the end of the weight loss intervention

    8 weeks

  • Change from baseline in fasting desire to eat using Visual Analogue scales at 8 weeks

    Measures of fasting desire to eat using Visual Analogue scales will be performed in fasting state (12h) at baseline and in the end of the weight loss intervention

    8 weeks

  • Change from baseline fasting fullness using Visual Analogue scales at 8 weeks

    Measures of fasting fullness using Visual Analogue scales will be performed in fasting state (12h) at baseline and in the end of the weight loss intervention

    8 weeks

  • Change from baseline in fasting prospective food consumption using Visual Analogue scales at 8 weeks

    Measures of fasting prospective food consumption using Visual Analogue scales will be performed in fasting state (12h) at baseline and in the end of the weight loss intervention

    8 weeks

  • Change from baseline in post-prandial hunger using Visual Analogue scales at 8 weeks

    Measures of post-prandial hunger using Visual Analogue scales will be taken at 30,60,90,120,150,180min after breakfast at baseline and in the end of the weight loss intervention

    8 weeks

  • Change from baseline in post-prandial desire to eat using Visual Analogue scales at 8 weeks

    Measures of post-prandial desire to eat using Visual Analogue scales will be taken at 30,60,90,120,150,180min after breakfast at baseline and in the end of the weight loss intervention

    8 weeks

  • Change from baseline in post-prandial fullness using Visual Analogue scales at 8 weeks

    Measures of post-prandial fullness using Visual Analogue scales will be taken at 30,60,90,120,150,180min after breakfast at baseline and in the end of the weight loss intervention

    8 weeks

  • Change from baseline in post-prandial prospective food consumption using Visual Analogue scales at 8 weeks

    Measures of post-prandial prospective food consumption using Visual Analogue scales will be taken at 30,60,90,120,150,180min after breakfast at baseline and in the end of the weight loss intervention

    8 weeks

Secondary Outcomes (14)

  • Change from baseline in Resting energy expenditure at 8 weeks

    8 weeks

  • Changes from baseline in post-prandial explicit liking using the LFPQ at 8 weeks

    8 weeks

  • Changes from baseline in post-prandial explicit wanting using the LFPQ at 8 weeks

    8 weeks

  • Changes from baseline in post-prandial implicit wanting using the LFPQ at 8 weeks

    8 weeks

  • Changes from baseline in olfaction using the 'Sniffin Sticks' tests at 8 weeks

    8 weeks

  • +9 more secondary outcomes

Study Arms (3)

Only diet group

EXPERIMENTAL

Dietary energy prescription at -30% of Energy requirements (50% carbohydrate; 30% fat; 20% protein) during 8 weeks. Follow up with a registered dietitian.

Behavioral: Caloric Restriction

Only cold exposure group

EXPERIMENTAL

No dietary intervention. Visit at laboratory every 2nd day during the 8-week intervention to undergo the cold exposure as follows: 2 weeks of exposure at 18 degrees, 2 weeks of exposure at 14 degrees and 4 weeks of 10 degrees of exposure during 90 min.

Other: Cold intervention

Combined diet + cold exposure group

EXPERIMENTAL

Dietary energy prescription at -30% of Energy requirements (50% carbohydrate; 30% fat; 20% protein). Follow up with a registered dietitian. Visit at laboratory every 2nd day during the 8-week intervention to undergo the cold exposure as follows: 2 weeks of exposure at 18 degrees, 2 weeks of exposure at 14 degrees and 4 weeks of 10 degrees of exposure during during 90 min.

Behavioral: Caloric Restriction

Interventions

-30% of participants total energy requirements

Combined diet + cold exposure groupOnly diet group

Sessions of 90min each every 2nd day involving cold exposure

Only cold exposure group

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Present a 27≥BMI,
  • Present a waist circumference \>88 cm
  • Must be weight-stable (±2 kg last 6 months)
  • Must be sedentary (\<2 times/week of 30 min of continuous exercise)
  • Must be able to read in English
  • Must to present no history of alcohol or drugs abuse
  • In addition, Women will be included if:
  • Must be pre-menopausal with a regular menstrual cycle

You may not qualify if:

  • present any history or evidence of cardiovascular disease
  • present any history or evidence of peripheral vascular disease
  • present any history or evidence of stroke
  • present a current diagnosis of an axis 1 psychiatric disorder (i.e. mood, anxiety and eating disorders);
  • be insulin dependent (75g oral glucose tolerance test)
  • present a known renal and/or liver disease
  • asthma requiring therapy
  • plasma cholesterol \> 8 mmol/L
  • systolic blood pressure \> 140 mmHg or diastolic blood pressure \> 90 mmHg
  • present previous history of inflammation disease
  • present previous history of cancer
  • present untreated thyroid or pituitary disease
  • present a regular consumption of medications that could affect cardiovascular function and/or metabolism (i.e. MAO inhibitors, pressor agents, warfarin, anticonvulsants, phenylbutazone, or tricyclic antidepressants)
  • present food allergies
  • be smoker
  • +5 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Ottawa

Ottawa, Ontario, K1N6N5, Canada

RECRUITING

MeSH Terms

Conditions

Weight LossAppetitive BehaviorObesity

Interventions

Caloric Restriction

Condition Hierarchy (Ancestors)

Body Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior, AnimalBehaviorOverweightOvernutritionNutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsEnergy IntakeDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Eric Doucet, PhD

    University of Ottawa

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Luzia Jaeger-Hintze, PhD

CONTACT

Eric Doucet, Prof

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study is an 8 week weight loss intervention with 3 randomly assigned groups: DIET, cold exposure (CE), and DIET+CE. Participants in the CE and DIET+CE groups will report to the laboratory every 2nd day for the 8 week intervention to undergo cold exposure. The DIET and DIET+CE groups will have a weekly nutritional consultation at the lab as well as a weekly check-in with the nutritionist via text, phone, or email.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Professor

Study Record Dates

First Submitted

April 26, 2021

First Posted

October 13, 2021

Study Start

February 1, 2022

Primary Completion

August 31, 2022

Study Completion

October 31, 2024

Last Updated

April 27, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations